Publications:

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.

Cancer Discovery

Hong, David S DS; Morris, Van K VK; El Osta, Badi B; Sorokin, Alexey V AV; Janku, Filip F; Fu, Siqing S; Overman, Michael J MJ; Piha-Paul, Sarina S; Subbiah, Vivek V; Kee, Bryan B; Tsimberidou, Apostolia M AM; Fogelman, David D; Bellido, Jorge J; Shureiqi, Imad I; Huang, Helen H; Atkins, Johnique J; Tarcic, Gabi G; Sommer, Nicolas N; Lanman, Richard R; Meric-Bernstam, Funda F; Kopetz, Scott S

Publication Date: 2016-12

Variant appearance in text: ERBB2: R552S

PubMed Link: 27729313

Variant Present in the following documents:

• Main text

View BVdb publication page